Nasopharyngeal Rapid diagnostic test
Genedia W / Covid – 19 Ag
Rapid nasopharyngeal swab useful for obtaining the Green Pass
GENEDIA W COVID-19 Ag device is a chromatographic immunoassay for the qualitative detection of specific antigens to COVID-19 present in human nasopharyngeal swab and sputum.
EImmediate on-site Antigen testing
• Allow wider testing with fast test time (10 minutes)
• Various type of specimen are available (Nasopharyngeal swab and sputum)
• Clinically proven data of asymptomatic patients available (Sensitivity in asymptomatic patients: 85%)
Specifications
Method: Immunochromatography
Packing unit: 20Tests / kit
Certification: CE-IVD
Specimen: Nasopharyngeal swab and sputum
LOD: 7.50X102 TCID50/mL
Running time: 10 minutes
Expiry date: 24 months from the date of manufacture
Storage condition: 2 ~ 30℃
Materials provided:
① Test device : 20 EA
② Extraction solution : 20 EA(10X2)
③ Sample developing filter cap : 20 EA
④ Sterilized swabs for sample collection : 20 EA
⑤ Instructions for use : 1 EA
Documentation to download
Sensitivity
Clinical sensitivity: 90.1% (95% CI : 85.1% - 93.9%)Specificity
Clinical specificity: 100% (95% CI : 98.4% - 100%)Total Agreement Ratio
Total Agreement Ratio: 95.3%
Scientific information:
Licia Vitale
+39 0577 1521219
licia.vitale@vismederipharma.com
Commercial information:
Simone Paletti
+39 0577 1521063
simone.paletti@vismederipharma.com
VisMederi Pharma srl - P.IVA 01532360524 - All rights reserved ® 2021